These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 19605798)

  • 21. ASHP guidelines on compounding sterile preparations.
    American Society of Health System Pharmacists
    Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608
    [No Abstract]   [Full Text] [Related]  

  • 22. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
    Allen LV
    Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of United States Pharmacopeia chapter 797: results of a national survey.
    Candy TA; Schneider PJ; Pedersen CA
    Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an aseptic technique testing and challenge kit (ATTACK).
    Turco S; Miele WH; Barnoski D
    Hosp Pharm; 1993 Jan; 28(1):11-3, 16-8. PubMed ID: 10124004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
    Lin SY; Houser SM; Gross G; Aaronson D
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive intravenous admixture services: logistics and quality assurance in a university affiliated teaching institution.
    Wellman GS; Hale KM; Schneider PJ; Hale KN
    Hosp Pharm; 1984 Sep; 19(9):601-6. PubMed ID: 10267935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential impact of USP 797 and what the JCAAI is doing about it.
    Nathan R
    Allergy Asthma Proc; 2007; 28(2):236-7. PubMed ID: 17479611
    [No Abstract]   [Full Text] [Related]  

  • 30. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
    Marks Z
    Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
    Vu N; Nguyen K; Kupiec TC
    Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of patient related parenteral nutrition solutions].
    Schroeder W
    Beitr Infusionther Klin Ernahr; 1986; 14():79-81. PubMed ID: 3096304
    [No Abstract]   [Full Text] [Related]  

  • 33. Sterility of extemporaneously compounded preservative-free injections.
    Levchuk JW
    Am J Hosp Pharm; 1991 Jan; 48(1):71-2. PubMed ID: 2053941
    [No Abstract]   [Full Text] [Related]  

  • 34. Parenteral nutrition in hospital pharmacies.
    Katoue MG; Al-Taweel D; Matar KM; Kombian SB
    Int J Health Care Qual Assur; 2016 Jul; 29(6):664-74. PubMed ID: 27298063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of extemporaneously compounded nitroglycerin ointment.
    Azarnoff DL; Lee JC; Lee C; Chandler J; Karlin D
    Dis Colon Rectum; 2007 Apr; 50(4):509-16. PubMed ID: 17476559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.
    Sunenshine RH; Tan ET; Terashita DM; Jensen BJ; Kacica MA; Sickbert-Bennett EE; Noble-Wang JA; Palmieri MJ; Bopp DJ; Jernigan DB; Kazakova S; Bresnitz EA; Tan CG; McDonald LC
    Clin Infect Dis; 2007 Sep; 45(5):527-33. PubMed ID: 17682984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of safe practices for parenteral nutrition formulations. American Society Parenteral and Enteral Nutrition.
    Kumpf VJ
    Am J Health Syst Pharm; 1999 Apr; 56(8):815-7. PubMed ID: 10326617
    [No Abstract]   [Full Text] [Related]  

  • 39. Parenteral nutrition training for the pharmacy team: focus on pharmacy technicians.
    Cassano AT
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):48S-50S. PubMed ID: 22275327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions.
    Bonnabry P; Cingria L; Sadeghipour F; Ing H; Fonzo-Christe C; Pfister RE
    Qual Saf Health Care; 2005 Apr; 14(2):93-8. PubMed ID: 15805453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.